Vitamin D oral rinsing reduces salivary SARS-CoV-2 antigen detectability: a clinical trial with public health implications.

Publication date: Jul 20, 2026

To determine whether a Vitamin D oral rinse alters the performance of saliva-based SARS-CoV-2 rapid antigen testing (RAT) and assess its potential implications for infectious disease screening and public health surveillance. In this prospective, paired-sample, single-blind clinical trial, 25 adults with laboratory-confirmed SARS-CoV-2 infection provided saliva immediately before and after a standardized one-minute Vitamin D₃ oral rinse (50 paired specimens). Samples were analyzed in parallel by saliva RAT and rapid RT-PCR under blinded conditions. The oral rinse converted 68% (17/25) of paired specimens from RAT-positive to RAT-negative, reducing antigen positivity from 54. 2% to 32. 0% (p = 0. 0016). In contrast, RT-PCR positivity remained largely preserved (96. 0% vs. 88. 0%), with no significant change in mean Ct values (28. 1 +/- 5. 9 vs. 29. 4 +/- 5. 1; p = 0. 1785). Strong concordance between paired RT-PCR samples (ρ = 0. 814, p 

Open Access PDF

Concepts Keywords
pre-analytical interference
public health surveillance
saliva
SARS-CoV-2

Semantics

Type Source Name
drug DRUGBANK Vitamin D
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
pathway REACTOME Reproduction
disease MESH emergency
disease MESH infection
drug DRUGBANK Cholecalciferol
pathway REACTOME Antimicrobial peptides
disease MESH bed

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *